News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Tasc Pharmaceuticals Ltd. To Merge With Glenmark Laboratories Ltd


10/19/2005 5:12:59 PM

GLENMARK Laboratories Ltd and Tasc Pharmaceuticals Ltd have amalgamated their operations to form a combined entity that will have a presence in the entire pharmaceutical value chain. Mr Mark Saldanha, Managing Director of the unlisted Glenmark Labs, told newspersons that the combined entity is valued at Rs 1,200 crore. Having a presence in pharmaceuticals and biologicals, the merged entity would be present both in the bulk drug and the finished dosage form segments, he said.

Read at FDA
Read at The Hindu Business Line

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES